Clinical Trial Update: Prospective, Multicenter Study of the Second Generation Antimicrobial Graft in the Abdominal Position [Phase 4]

View source ↗

Summary

Phase 4 multicenter trial evaluating a second generation antimicrobial graft for abdominal aorta aneurysm and occlusive disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Disease of the Abdominal Aorta
• Occlusive Disease of the Abdominal Aorta

Drugs mentioned

• Second Generation Antimicrobial Graft

Snippet

Sponsor: Datascope Corp. | Conditions: Aneurysmal Disease of the Abdominal Aorta, Occlusive Disease of the Abdominal Aorta | Phase 4 | Status: UNKNOWN